PT-141
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin agonist (CAS 189691-06-3) at 99.5% HPLC-verified purity. Studied for MC3R/MC4R receptor binding and CNS neuropeptide signaling.
PT-141 — Research Summary
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. Unlike its precursor, PT-141 does not contain a tanning effect and is studied specifically for its central nervous system activity via melanocortin MC3R and MC4R receptor pathways. Research has focused on its role in modulating neuropeptide signaling pathways in hypothalamic circuits. Supplied as lyophilized powder. For laboratory research use only.
Researchers Also Study
For research use only. Not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used solely for lawful laboratory research.